scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1177/088307389701200202 |
P698 | PubMed publication ID | 9075015 |
P2093 | author name string | M I Phillips | |
B L Maria | |||
K B Hoang | |||
C D Medina | |||
P2860 | cites work | Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes | Q28253669 |
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction | Q34354588 | ||
Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors | Q36362722 | ||
Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase | Q36728931 | ||
Transfer of genes to humans: early lessons and obstacles to success | Q40418899 | ||
Myoblast transfer and gene therapy in muscular dystrophies | Q40437473 | ||
Gene therapy and pharmacological treatment of inherited neurological disorders | Q40535858 | ||
Gene therapy for solid tumors | Q40537219 | ||
Gene therapy and immune restoration for HIV disease | Q40591308 | ||
Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis | Q40624060 | ||
Gene therapy for neurologic disease | Q40769415 | ||
Gene therapy for neurologic disease: benchtop discoveries to bedside applications. 1. The bench | Q41332176 | ||
Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir | Q41576545 | ||
Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector | Q41590056 | ||
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells | Q42812729 | ||
A plasmid-based self-amplifying Sindbis virus vector | Q42824740 | ||
Direct gene transfer into nonhuman primate myofibers in vivo | Q43851694 | ||
Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice | Q45716447 | ||
Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention | Q45782573 | ||
Gene therapy for brain tumors in trials, correction of inherited disorders a hope | Q45875013 | ||
Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II). | Q45878645 | ||
Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions | Q48283998 | ||
Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs | Q59080986 | ||
P433 | issue | 2 | |
P921 | main subject | gene therapy | Q213901 |
P304 | page(s) | 77-84 | |
P577 | publication date | 1997-02-01 | |
P1433 | published in | Journal of Child Neurology | Q6294935 |
P1476 | title | Gene therapy for neurologic disease: benchtop discoveries to bedside applications. 2. The bedside | |
P478 | volume | 12 |
Search more.